Medpace Holdings, Inc. (MEDP): EPS (Basic)
$15.64
Year ended 2025-12-31
+27.4%
3-year compound annual growth
+30.9%
5-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.64 | +19.8% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $13.06 | +42.0% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $9.20 | +21.5% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $7.57 | +49.6% | 2025-02-11, From 2022-01-01 |
| 2021-12-31 | $5.06 | +24.3% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $4.07 | +45.9% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $2.79 | +36.1% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $2.05 | +105.0% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $1.00 | +163.2% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $0.38 | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$0.28 | n/a | 2018-02-27, From 2015-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $15.64 | +19.8% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | -$2.91 | n/m |
| Incyte Corp (INCY) | 2025-12-31 | $6.59 | n/m |
| Icon PLC (ICLR) | 2025-12-31 | $2.92 | -67.4% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $7.91 | +4.5% |
| NRC Health (NRC) | 2025-12-31 | $50.00 | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$0.42 | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$0.57 | n/m |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | -$8.66 | n/m |
Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗